---
title: "LifeSci Capital Remains a Buy on Ibio (IBIO)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286648765.md"
description: "LifeSci Capital's Patrick Dolezal has maintained a Buy rating on Ibio (IBIO) with a price target of $5.00. The analyst consensus for Ibio is a Strong Buy, with an average price target of $5.80. Dolezal has an average return of 15.0% and a 43.63% success rate on his stock recommendations."
datetime: "2026-05-16T14:36:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286648765.md)
  - [en](https://longbridge.com/en/news/286648765.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286648765.md)
generator: "portal-rs"
---

# LifeSci Capital Remains a Buy on Ibio (IBIO)

In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Ibio, with a price target of $5.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Dolezal covers the Healthcare sector, focusing on stocks such as Ibio, Neurogene, and Rocket Pharmaceuticals. According to TipRanks, Dolezal has an average return of 15.0% and a 43.63% success rate on recommended stocks. 

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ibio with a $5.80 average price target.

### Related Stocks

- [IBIO.US](https://longbridge.com/en/quote/IBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [NGNE.US](https://longbridge.com/en/quote/NGNE.US.md)
- [RCKT.US](https://longbridge.com/en/quote/RCKT.US.md)
- [RCKTW.US](https://longbridge.com/en/quote/RCKTW.US.md)

## Related News & Research

- [iBio FY26 net loss widens to $33.04 million; revenue drops to $100,000](https://longbridge.com/en/news/297313027.md)
- [iBio advances IBIO-600 into Phase 1 multiple-ascending-dose trial stage after completing single-ascending-dose dosing](https://longbridge.com/en/news/297325770.md)
- [iBio (IBIO) Expected to Release Quarterly Earnings on Friday](https://longbridge.com/en/news/297268019.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)
- [EverGen Infrastructure Reports Q2 2026 Results | EVGIF Stock News](https://longbridge.com/en/news/297122882.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**